Medical Subject Headings

Last uploaded: March 22, 2026

Id	http://purl.bioontology.org/ontology/MESH/C575292 http://purl.bioontology.org/ontology/MESH/C575292
Preferred Name	dodecyl-3-((1-(3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)carbamoyl)pyrazine-2-carboxylate
Synonyms	SL-01
Type	http://www.w3.org/2002/07/owl#Class

altLabel	SL-01
prefLabel	dodecyl-3-((1-(3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)carbamoyl)pyrazine-2-carboxylate
Scope Statement	has antineoplastic activity; structure in first source
type	http://www.w3.org/2002/07/owl#Class
tui	T114 T121
Has mapping qualifier	http://purl.bioontology.org/ontology/MESH/Q000031
HM	D003841/Q000031
SC	1
TERMUI	T830561 T830562
TH	NLM (2013)
SRC	Toxicol Appl Pharmacol. 2012 Aug 1;262(3):293-300.
MMR	20120930
notation	C575292
Semantic type UMLS property	http://purl.bioontology.org/ontology/STY/T121 http://purl.bioontology.org/ontology/STY/T114
cui	C3502594 C3502593
MeSH Frequency	3
DSC	20120930
Inverse of RB	0
Mapped to	http://purl.bioontology.org/ontology/MESH/D003841
MDA	20120930

Delete	Subject	Author	Type	Created
No notes to display